Literature DB >> 4216720

Long-term therapy of hereditary angioedema (HAE). Preventive management with fluoxymesterone and oxymetholone in severely affected males and females.

P J Davis, F B Davis, P Charache.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4216720

Source DB:  PubMed          Journal:  Johns Hopkins Med J        ISSN: 0021-7263


× No keyword cloud information.
  7 in total

1.  Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives.

Authors:  Stephen A Tilles; Larry Borish; Joshua P Cohen
Journal:  Ann Allergy Asthma Immunol       Date:  2012-12-17       Impact factor: 6.347

Review 2.  Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency).

Authors:  A Fay; M Abinun
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Complement in respiratory immunopathology.

Authors:  C Molina; J Brun; D Wahl
Journal:  Lung       Date:  1979       Impact factor: 2.584

4.  Treatment of hereditary angioneurotic oedema with methandienone.

Authors:  E M Saihan; R P Warin
Journal:  Br Med J       Date:  1978-02-11

Review 5.  C1 inhibitor deficiency: consensus document.

Authors:  M M Gompels; R J Lock; M Abinun; C A Bethune; G Davies; C Grattan; A C Fay; H J Longhurst; L Morrison; A Price; M Price; D Watters
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

6.  Response of variant hereditary angioedema phenotypes to danazol therapy. Genetic implications.

Authors:  J E Gadek; S W Hosea; J A Gelfand; M M Frank
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Effect of dehydroepiandrosterone on hereditary angioedema.

Authors:  E Koó; K G Fehér; T Fehér; G Füst
Journal:  Klin Wochenschr       Date:  1983-07-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.